Eastwood Bio Revenue vs. Return On Equity

EBM Stock  CAD 0.54  0.11  16.92%   
Considering Eastwood Bio's profitability and operating efficiency indicators, Eastwood Bio Medical Canada may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Eastwood Bio's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2013-07-31
Previous Quarter
201 K
Current Value
135.2 K
Quarterly Volatility
104 K
 
Yuan Drop
 
Covid
At this time, Eastwood Bio's Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to climb to 157.22 in 2024, whereas Days Sales Outstanding is likely to drop 17.89 in 2024. Accumulated Other Comprehensive Income is likely to drop to 7,611 in 2024. Operating Income is likely to drop to about (478.2 K) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.40.57
Way Down
Slightly volatile
For Eastwood Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eastwood Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eastwood Bio Medical Canada utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eastwood Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eastwood Bio Medical Canada over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Eastwood Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eastwood Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eastwood Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eastwood Bio Medical Return On Equity vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Eastwood Bio's current stock value. Our valuation model uses many indicators to compare Eastwood Bio value to that of its competitors to determine the firm's financial worth.
Eastwood Bio Medical Canada is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in return on equity category among its peers . At this time, Eastwood Bio's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastwood Bio's earnings, one of the primary drivers of an investment's value.

Eastwood Revenue vs. Competition

Eastwood Bio Medical Canada is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Consumer Staples industry is currently estimated at about 51.45 Million. Eastwood Bio claims roughly 867,936 in revenue contributing just under 2% to stocks in Consumer Staples industry.

Eastwood Return On Equity vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Eastwood Bio

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
867.94 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Eastwood Bio

Return On Equity

 = 

Net Income

Total Equity

 = 
-7.47
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Eastwood Return On Equity Comparison

Eastwood Bio is currently under evaluation in return on equity category among its peers.

Eastwood Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Eastwood Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eastwood Bio will eventually generate negative long term returns. The profitability progress is the general direction of Eastwood Bio's change in net profit over the period of time. It can combine multiple indicators of Eastwood Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income8.6 K7.6 K
Operating Income-455.4 K-478.2 K
Net Loss-491.9 K-516.5 K
Income Before Tax-491.9 K-516.5 K
Total Other Income Expense Net-36.5 K-38.3 K
Net Loss-134.9 K-141.6 K
Net Loss-491.9 K-516.5 K
Income Tax Expense(1.15)(1.21)
Net Interest Income-25.3 K-24.1 K
Change To Netincome5.3 K5.1 K
Net Loss(0.01)(0.01)
Income Quality 0.03  0.03 

Eastwood Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Eastwood Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eastwood Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eastwood Bio's important profitability drivers and their relationship over time.

Use Eastwood Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eastwood Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastwood Bio will appreciate offsetting losses from the drop in the long position's value.

Eastwood Bio Pair Trading

Eastwood Bio Medical Canada Pair Trading Analysis

The ability to find closely correlated positions to Eastwood Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eastwood Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eastwood Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eastwood Bio Medical Canada to buy it.
The correlation of Eastwood Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eastwood Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eastwood Bio Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eastwood Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Eastwood Bio position

In addition to having Eastwood Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Agency Mbs ETFs Thematic Idea Now

Agency Mbs ETFs
Agency Mbs ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Agency Mbs ETFs theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agency Mbs ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.